Some patients with breast cancer face unacceptable delaysMay 22, 2002Some patients with breast cancer are waiting up to 12 weeks for diagnosis and treatment, despite the introduction of a two week wait initiative by the government, suggest researchers in this week’s BMJ. Using data from the breast unit at King’s College Hospital, the team examined all general practitioners’ referrals to the breast clinic between April 1999 and December 2000. Altogether 3,597 referrals were made, 665 were marked as urgent and 2,932 as non-urgent. Sixty-two urgent patients and 49 non-urgent patients were subsequently found to have breast cancer. It is evident that the two week wait initiative is not ensuring that most patients with symptomatic cancer are seen within two weeks of referral, say the authors. The emphasis on seeing urgent cases within the time has been at the expense of the non-urgent cases. Waiting times in this group have increased to 12 weeks in some units. “By grading patient referrals, we are creating a two tier structure, with patients in the non-urgent group waiting longer periods for diagnosis and treatment. For patients with cancers in this group the delay can be critical,” they argue. As no grading system is perfect, the only way of guaranteeing that all patients with breast cancer are seen within two weeks is by seeing all the referrals in this period. This has become achievable at our unit through managing capacity and demand, they conclude. British Medical Journal (BMJ) |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||